195 related articles for article (PubMed ID: 37700495)
1. Deubiquitinase USP19 modulates apoptotic calcium release and endoplasmic reticulum stress by deubiquitinating BAG6 in triple negative breast cancer.
Zhang X; Chen X; Qian F; Zhu Y; He G; Yang J; Wu X; Zhang H; Yu X; Liu X
Clin Transl Med; 2023 Sep; 13(9):e1398. PubMed ID: 37700495
[TBL] [Abstract][Full Text] [Related]
2. Activation of the membrane-bound Nrf1 transcription factor by USP19, a ubiquitin-specific protease C-terminally anchored in the endoplasmic reticulum.
Hu S; Xiang Y; Qiu L; Wang M; Zhang Y
Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119299. PubMed ID: 35613680
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the deubiquitinating activity of USP19 and its role in endoplasmic reticulum-associated degradation.
Lee JG; Kim W; Gygi S; Ye Y
J Biol Chem; 2014 Feb; 289(6):3510-7. PubMed ID: 24356957
[TBL] [Abstract][Full Text] [Related]
4. Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial-mesenchymal transition of breast cancer cells.
Zhang J; van Dinther M; Thorikay M; Gourabi BM; Kruithof BPT; Ten Dijke P
Cell Mol Life Sci; 2023 Jan; 80(2):43. PubMed ID: 36646950
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific protease 19 regulates the stability of the E3 ubiquitin ligase MARCH6.
Nakamura N; Harada K; Kato M; Hirose S
Exp Cell Res; 2014 Oct; 328(1):207-216. PubMed ID: 25088257
[TBL] [Abstract][Full Text] [Related]
6. SIAH1 modulates antiviral immune responses by targeting deubiquitinase USP19.
Weerawardhana A; Herath TUB; Gayan Chathuranga WA; Kim TH; Ekanayaka P; Chathuranga K; Kang HC; Jung JU; Lee JS
J Med Virol; 2024 Mar; 96(3):e29523. PubMed ID: 38483060
[TBL] [Abstract][Full Text] [Related]
7. USP19-Mediated Deubiquitination Facilitates the Stabilization of HRD1 Ubiquitin Ligase.
Harada K; Kato M; Nakamura N
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827840
[TBL] [Abstract][Full Text] [Related]
8. Ilamycin E, a natural product of marine actinomycete, inhibits triple-negative breast cancer partially through ER stress-CHOP-Bcl-2.
Zhou W; Fang H; Wu Q; Wang X; Liu R; Li F; Xiao J; Yuan L; Zhou Z; Ma J; Wang L; Zhao W; You H; Ju J; Feng J; Chen C
Int J Biol Sci; 2019; 15(8):1723-1732. PubMed ID: 31360114
[TBL] [Abstract][Full Text] [Related]
9. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
[TBL] [Abstract][Full Text] [Related]
10. A ubiquitin-like domain recruits an oligomeric chaperone to a retrotranslocation complex in endoplasmic reticulum-associated degradation.
Xu Y; Liu Y; Lee JG; Ye Y
J Biol Chem; 2013 Jun; 288(25):18068-76. PubMed ID: 23665563
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine.
Ghosh S; Adhikary A; Chakraborty S; Bhattacharjee P; Mazumder M; Putatunda S; Gorain M; Chakraborty A; Kundu GC; Das T; Sen PC
J Biol Chem; 2015 Feb; 290(7):3936-49. PubMed ID: 25527500
[TBL] [Abstract][Full Text] [Related]
12. The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2.
Mei Y; Hahn AA; Hu S; Yang X
J Biol Chem; 2011 Oct; 286(41):35380-35387. PubMed ID: 21849505
[TBL] [Abstract][Full Text] [Related]
13. A marine-derived small molecule induces immunogenic cell death against triple-negative breast cancer through ER stress-CHOP pathway.
Wen H; Zhong Y; Yin Y; Qin K; Yang L; Li D; Yu W; Yang C; Deng Z; Hong K
Int J Biol Sci; 2022; 18(7):2898-2913. PubMed ID: 35541893
[TBL] [Abstract][Full Text] [Related]
14. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
Yin C; Dai X; Huang X; Zhu W; Chen X; Zhou Q; Wang C; Zhao C; Zou P; Liang G; Rajamanickam V; Wang O; Zhang X; Cui R
J Cell Mol Med; 2019 Mar; 23(3):2194-2206. PubMed ID: 30609207
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic Ubiquitin-Specific Protease 19 (USP19) Modulates Aggregation of Polyglutamine-Expanded Ataxin-3 and Huntingtin through the HSP90 Chaperone.
He WT; Zheng XM; Zhang YH; Gao YG; Song AX; van der Goot FG; Hu HY
PLoS One; 2016; 11(1):e0147515. PubMed ID: 26808260
[TBL] [Abstract][Full Text] [Related]
16. USP19 deubiquitinating enzyme inhibits muscle cell differentiation by suppressing unfolded-protein response signaling.
Wiles B; Miao M; Coyne E; Larose L; Cybulsky AV; Wing SS
Mol Biol Cell; 2015 Mar; 26(5):913-23. PubMed ID: 25568336
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of endoplasmic reticulum stress alleviates triple-negative breast cancer cell viability, migration, and invasion by Syntenin/SOX4/Wnt/β-catenin pathway via regulation of heat shock protein A4.
Nan J; Hu X; Guo B; Xu M; Yao Y
Bioengineered; 2022 Apr; 13(4):10564-10577. PubMed ID: 35442158
[TBL] [Abstract][Full Text] [Related]
18. Involvement of both caspase-8 and Noxa-activated pathways in endoplasmic reticulum stress-induced apoptosis in triple-negative breast tumor cells.
Cano-González A; Mauro-Lizcano M; Iglesias-Serret D; Gil J; López-Rivas A
Cell Death Dis; 2018 Jan; 9(2):134. PubMed ID: 29374147
[TBL] [Abstract][Full Text] [Related]
19. IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
Harnoss JM; Le Thomas A; Reichelt M; Guttman O; Wu TD; Marsters SA; Shemorry A; Lawrence DA; Kan D; Segal E; Merchant M; Totpal K; Crocker LM; Mesh K; Dohse M; Solon M; Modrusan Z; Rudolph J; Koeppen H; Walter P; Ashkenazi A
Cancer Res; 2020 Jun; 80(11):2368-2379. PubMed ID: 32265225
[TBL] [Abstract][Full Text] [Related]
20. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP.
Tian Z; Xu C; He W; Lin Z; Zhang W; Tao K; Ding R; Zhang X; Dou K
Cancer Lett; 2023 Nov; 577():216439. PubMed ID: 37832781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
